Qianxing Mo

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. pmc A microarray analysis of sex- and gonad-biased gene expression in the zebrafish: evidence for masculinization of the transcriptome
    Clayton M Small
    Department of Biology, Texas A and M University, College Station, TX, USA
    BMC Genomics 10:579. 2009
  2. doi A hidden Ising model for ChIP-chip data analysis
    Qianxing Mo
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Bioinformatics 26:777-83. 2010
  3. doi Bayesian modeling of ChIP-chip data through a high-order Ising model
    Qianxing Mo
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Biometrics 66:1284-94. 2010
  4. doi A fully Bayesian hidden Ising model for ChIP-seq data analysis
    Qianxing Mo
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Biostatistics 13:113-28. 2012
  5. doi Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies
    Karyn A Goodman
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 78:486-93. 2010
  6. doi Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT
    Israel Deutsch
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center New York, New York, NY10021, USA
    Brachytherapy 9:313-8. 2010
  7. doi Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein
    Rachel Kobos
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, USA
    J Pathol 229:743-54. 2013
  8. pmc Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI
    Michael H Fuchsjäger
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 78:743-50. 2010
  9. doi Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy
    Ian Ganly
    Memorial Sloan Kettering Cancer Center Human Oncology and Pathogenesis Program, 1275 York Avenue, New York, New York 10065, USA
    J Clin Endocrinol Metab 98:E962-72. 2013

Collaborators

Detail Information

Publications9

  1. pmc A microarray analysis of sex- and gonad-biased gene expression in the zebrafish: evidence for masculinization of the transcriptome
    Clayton M Small
    Department of Biology, Texas A and M University, College Station, TX, USA
    BMC Genomics 10:579. 2009
    ..Here we use a microarray assessment of sex- and gonad-biased gene expression to test this hypothesis in zebrafish...
  2. doi A hidden Ising model for ChIP-chip data analysis
    Qianxing Mo
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Bioinformatics 26:777-83. 2010
    ..To overcome this limitation and to develop an efficient software, we propose a hidden ferromagnetic Ising model for ChIP-chip data analysis...
  3. doi Bayesian modeling of ChIP-chip data through a high-order Ising model
    Qianxing Mo
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Biometrics 66:1284-94. 2010
    ..In addition, we find that the proposed method has better operating characteristics in terms of sensitivities and false discovery rates under various scenarios...
  4. doi A fully Bayesian hidden Ising model for ChIP-seq data analysis
    Qianxing Mo
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Biostatistics 13:113-28. 2012
    ..The results indicate that the proposed method achieves equivalent or higher sensitivity and spatial resolution in detecting TF binding sites with false discovery rate at a much lower level...
  5. doi Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies
    Karyn A Goodman
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 78:486-93. 2010
    ..We performed a Phase I dose-escalation study to explore the feasibility and safety of treating primary and metastatic liver tumors with single-fraction stereotactic body radiotherapy (SBRT)...
  6. doi Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT
    Israel Deutsch
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center New York, New York, NY10021, USA
    Brachytherapy 9:313-8. 2010
    ..a lower dose of IMRT combined with high-dose-rate (HDR) brachytherapy to increase the biologically effective dose of IMRT...
  7. doi Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein
    Rachel Kobos
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, USA
    J Pathol 229:743-54. 2013
    ..More generally, this work establishes a combined integrated genomics/functional genomics strategy to dissect the biology of oncogenic, chimeric transcription factors...
  8. pmc Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI
    Michael H Fuchsjäger
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 78:743-50. 2010
    ..To investigate whether pretreatment endorectal magnetic resonance imaging (MRI) findings can predict biochemical relapse in patients with clinically localized prostate cancer treated with external beam radiation therapy (EBRT)...
  9. doi Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy
    Ian Ganly
    Memorial Sloan Kettering Cancer Center Human Oncology and Pathogenesis Program, 1275 York Avenue, New York, New York 10065, USA
    J Clin Endocrinol Metab 98:E962-72. 2013
    ..Hurthle cell cancer (HCC) is an understudied cancer with poor prognosis...